Grazax: sublingual immunotherapy for grass pollen allergy

Grazax is a novel sublingual formulation of grass pollen allergen for the treatment of hay fever in adults. In our Drugs in focus review Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Professor Stephen Durham comments on its place in therapy. Copyright © 2008 Wiley Interface Ltd